aluates Reports

$ 0.0

Automative

Global Pneumococcal Vaccine Market Research Report 2026

Published Date: 2026-01-19

Report Code: QYRE-Auto-37E406

Global Pneumococcal Vaccine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Pneumococcal Vaccine Market Research Report 2026

Code: QYRE-Auto-37E406

Report

2026-01-19

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

GSK

MSD

Sanofipasteur

CDIBP

Pneumococcal Vaccine Market Size

The global Pneumococcal Vaccine market was valued at US$ 7431 million in 2025 and is anticipated to reach US$ 8014 million by 2032, at a CAGR of 1.1% from 2026 to 2032.

Pneumococcal Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pneumococcal Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.

North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

This report delivers a comprehensive overview of the global Pneumococcal Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pneumococcal Vaccine. The Pneumococcal Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Doses) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pneumococcal Vaccine market comprehensively. Regional market sizes by Type, by End User, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pneumococcal Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by End User, and by region.

Market Segmentation

Scope of Pneumococcal Vaccine Market Report

Report Metric	Details
Report Name	Pneumococcal Vaccine Market
Accounted market size in 2025	US$ 7431 million
Forecasted market size in 2032	US$ 8014 million
CAGR	1.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	PPSV 23 PCV 7/13 PCV 10
by End User	Child Adult
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, GSK, MSD, Sanofipasteur, CDIBP
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by End User, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pneumococcal Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Pneumococcal Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by End User, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Pneumococcal Vaccine Market growing?

Ans: The Pneumococcal Vaccine Market witnessing a CAGR of 1.1% during the forecast period 2026-2032.

What is the Pneumococcal Vaccine Market size in 2032?

Ans: The Pneumococcal Vaccine Market size in 2032 will be US$ 8014 million.

What is the Pfizer share in Pneumococcal Vaccine Market?

Ans: Pfizer is the leader of this industry with 84% market shares.

What is the Pneumococcal Vaccine Market share by region?

Ans: North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

Who are the main players in the Pneumococcal Vaccine Market report?

Ans: The main players in the Pneumococcal Vaccine Market are Pfizer, GSK, MSD, Sanofipasteur, CDIBP

What are the Type segmentation covered in the Pneumococcal Vaccine Market report?

Ans: The Types covered in the Pneumococcal Vaccine Market report are PPSV 23, PCV 7/13, PCV 10

What are the End User segmentation covered in the Pneumococcal Vaccine Market report?

Ans: The End users covered in the Pneumococcal Vaccine Market report are Child, Adult

1 Pneumococcal Vaccine Market Overview

1.1 Product Definition

1.2 Pneumococcal Vaccine by Type

1.2.1 Global Pneumococcal Vaccine Market Value by Type: 2025 vs 2032

1.2.2 PPSV 23

1.2.3 PCV 7/13

1.2.4 PCV 10

1.3 Pneumococcal Vaccine by End User

1.3.1 Global Pneumococcal Vaccine Market Value by End User: 2025 vs 2032

1.3.2 Child

1.3.3 Adult

1.4 Global Pneumococcal Vaccine Market Size Estimates and Forecasts

1.4.1 Global Pneumococcal Vaccine Revenue 2021–2032

1.4.2 Global Pneumococcal Vaccine Sales 2021–2032

1.4.3 Global Pneumococcal Vaccine Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Pneumococcal Vaccine Market Competition by Manufacturers

2.1 Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2021–2026)

2.2 Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Pneumococcal Vaccine Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Pneumococcal Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Pneumococcal Vaccine, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Pneumococcal Vaccine, Product Types and Applications

2.7 Global Key Manufacturers of Pneumococcal Vaccine, Date of Entry into the Industry

2.8 Global Pneumococcal Vaccine Market Competitive Situation and Trends

2.8.1 Global Pneumococcal Vaccine Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Pneumococcal Vaccine Players Market Share by Revenue

2.8.3 Global Pneumococcal Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pneumococcal Vaccine Market Scenario by Region

3.1 Global Pneumococcal Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Pneumococcal Vaccine Sales by Region: 2021–2032

3.2.1 Global Pneumococcal Vaccine Sales by Region: 2021–2026

3.2.2 Global Pneumococcal Vaccine Sales by Region: 2027–2032

3.3 Global Pneumococcal Vaccine Revenue by Region: 2021–2032

3.3.1 Global Pneumococcal Vaccine Revenue by Region: 2021–2026

3.3.2 Global Pneumococcal Vaccine Revenue by Region: 2027–2032

3.4 North America Pneumococcal Vaccine Market Facts & Figures by Country

3.4.1 North America Pneumococcal Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Pneumococcal Vaccine Sales by Country (2021–2032)

3.4.3 North America Pneumococcal Vaccine Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pneumococcal Vaccine Market Facts & Figures by Country

3.5.1 Europe Pneumococcal Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Pneumococcal Vaccine Sales by Country (2021–2032)

3.5.3 Europe Pneumococcal Vaccine Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pneumococcal Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Pneumococcal Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Pneumococcal Vaccine Sales by Region (2021–2032)

3.6.3 Asia Pacific Pneumococcal Vaccine Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pneumococcal Vaccine Market Facts & Figures by Country

3.7.1 Latin America Pneumococcal Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Pneumococcal Vaccine Sales by Country (2021–2032)

3.7.3 Latin America Pneumococcal Vaccine Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pneumococcal Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Pneumococcal Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Pneumococcal Vaccine Sales by Country (2021–2032)

3.8.3 Middle East and Africa Pneumococcal Vaccine Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Pneumococcal Vaccine Sales by Type (2021–2032)

4.1.1 Global Pneumococcal Vaccine Sales by Type (2021–2026)

4.1.2 Global Pneumococcal Vaccine Sales by Type (2027–2032)

4.1.3 Global Pneumococcal Vaccine Sales Market Share by Type (2021–2032)

4.2 Global Pneumococcal Vaccine Revenue by Type (2021–2032)

4.2.1 Global Pneumococcal Vaccine Revenue by Type (2021–2026)

4.2.2 Global Pneumococcal Vaccine Revenue by Type (2027–2032)

4.2.3 Global Pneumococcal Vaccine Revenue Market Share by Type (2021–2032)

4.3 Global Pneumococcal Vaccine Price by Type (2021–2032)

5 Segment by End User

5.1 Global Pneumococcal Vaccine Sales by End User (2021–2032)

5.1.1 Global Pneumococcal Vaccine Sales by End User (2021–2026)

5.1.2 Global Pneumococcal Vaccine Sales by End User (2027–2032)

5.1.3 Global Pneumococcal Vaccine Sales Market Share by End User (2021–2032)

5.2 Global Pneumococcal Vaccine Revenue by End User (2021–2032)

5.2.1 Global Pneumococcal Vaccine Revenue by End User (2021–2026)

5.2.2 Global Pneumococcal Vaccine Revenue by End User (2027–2032)

5.2.3 Global Pneumococcal Vaccine Revenue Market Share by End User (2021–2032)

5.3 Global Pneumococcal Vaccine Price by End User (2021–2032)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Pfizer Pneumococcal Vaccine Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Pneumococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 GSK Pneumococcal Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 MSD

6.3.1 MSD Company Information

6.3.2 MSD Description and Business Overview

6.3.3 MSD Pneumococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 MSD Pneumococcal Vaccine Product Portfolio

6.3.5 MSD Recent Developments/Updates

6.4 Sanofipasteur

6.4.1 Sanofipasteur Company Information

6.4.2 Sanofipasteur Description and Business Overview

6.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio

6.4.5 Sanofipasteur Recent Developments/Updates

6.5 CDIBP

6.5.1 CDIBP Company Information

6.5.2 CDIBP Description and Business Overview

6.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 CDIBP Pneumococcal Vaccine Product Portfolio

6.5.5 CDIBP Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pneumococcal Vaccine Industry Chain Analysis

7.2 Pneumococcal Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pneumococcal Vaccine Production Mode & Process Analysis

7.4 Pneumococcal Vaccine Sales and Marketing

7.4.1 Pneumococcal Vaccine Sales Channels

7.4.2 Pneumococcal Vaccine Distributors

7.5 Pneumococcal Vaccine Customer Analysis

8 Pneumococcal Vaccine Market Dynamics

8.1 Pneumococcal Vaccine Industry Trends

8.2 Pneumococcal Vaccine Market Drivers

8.3 Pneumococcal Vaccine Market Challenges

8.4 Pneumococcal Vaccine Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Pfizer Inc

GSK

MSD

Sanofipasteur

CDIBP

List of Tables

Table 1. Global Pneumococcal Vaccine Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Pneumococcal Vaccine Market Value by End User (US$ Million), 2025 vs 2032

Table 3. Global Pneumococcal Vaccine Market Competitive Situation by Manufacturers in 2025

Table 4. Global Pneumococcal Vaccine Sales (K Doses) of Key Manufacturers (2021–2026)

Table 5. Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Pneumococcal Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Pneumococcal Vaccine Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Pneumococcal Vaccine Average Price (USD/Dose) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Pneumococcal Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Pneumococcal Vaccine, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Pneumococcal Vaccine, Product Types and Applications

Table 12. Global Key Manufacturers of Pneumococcal Vaccine, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pneumococcal Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pneumococcal Vaccine Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pneumococcal Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Pneumococcal Vaccine Sales by Region (K Doses), 2021–2026

Table 18. Global Pneumococcal Vaccine Sales Market Share by Region (2021–2026)

Table 19. Global Pneumococcal Vaccine Sales by Region (K Doses), 2027–2032

Table 20. Global Pneumococcal Vaccine Sales Market Share by Region (2027–2032)

Table 21. Global Pneumococcal Vaccine Revenue by Region (US$ Million), 2021–2026

Table 22. Global Pneumococcal Vaccine Revenue Market Share by Region (2021–2026)

Table 23. Global Pneumococcal Vaccine Revenue by Region (US$ Million), 2027–2032

Table 24. Global Pneumococcal Vaccine Revenue Market Share by Region (2027–2032)

Table 25. North America Pneumococcal Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Pneumococcal Vaccine Sales by Country (K Doses), 2021–2026

Table 27. North America Pneumococcal Vaccine Sales by Country (K Doses), 2027–2032

Table 28. North America Pneumococcal Vaccine Revenue by Country (US$ Million), 2021–2026

Table 29. North America Pneumococcal Vaccine Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Pneumococcal Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Pneumococcal Vaccine Sales by Country (K Doses), 2021–2026

Table 32. Europe Pneumococcal Vaccine Sales by Country (K Doses), 2027–2032

Table 33. Europe Pneumococcal Vaccine Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Pneumococcal Vaccine Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Pneumococcal Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Pneumococcal Vaccine Sales by Region (K Doses), 2021–2026

Table 37. Asia Pacific Pneumococcal Vaccine Sales by Region (K Doses), 2027–2032

Table 38. Asia Pacific Pneumococcal Vaccine Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Pneumococcal Vaccine Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Pneumococcal Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Pneumococcal Vaccine Sales by Country (K Doses), 2021–2026

Table 42. Latin America Pneumococcal Vaccine Sales by Country (K Doses), 2027–2032

Table 43. Latin America Pneumococcal Vaccine Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Pneumococcal Vaccine Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Pneumococcal Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Pneumococcal Vaccine Sales by Country (K Doses), 2021–2026

Table 47. Middle East and Africa Pneumococcal Vaccine Sales by Country (K Doses), 2027–2032

Table 48. Middle East and Africa Pneumococcal Vaccine Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Pneumococcal Vaccine Revenue by Country (US$ Million), 2027–2032

Table 50. Global Pneumococcal Vaccine Sales (K Doses) by Type (2021–2026)

Table 51. Global Pneumococcal Vaccine Sales (K Doses) by Type (2027–2032)

Table 52. Global Pneumococcal Vaccine Sales Market Share by Type (2021–2026)

Table 53. Global Pneumococcal Vaccine Sales Market Share by Type (2027–2032)

Table 54. Global Pneumococcal Vaccine Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Pneumococcal Vaccine Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Pneumococcal Vaccine Revenue Market Share by Type (2021–2026)

Table 57. Global Pneumococcal Vaccine Revenue Market Share by Type (2027–2032)

Table 58. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2021–2026)

Table 59. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2027–2032)

Table 60. Global Pneumococcal Vaccine Sales (K Doses) by End User (2021–2026)

Table 61. Global Pneumococcal Vaccine Sales (K Doses) by End User (2027–2032)

Table 62. Global Pneumococcal Vaccine Sales Market Share by End User (2021–2026)

Table 63. Global Pneumococcal Vaccine Sales Market Share by End User (2027–2032)

Table 64. Global Pneumococcal Vaccine Revenue (US$ Million) by End User (2021–2026)

Table 65. Global Pneumococcal Vaccine Revenue (US$ Million) by End User (2027–2032)

Table 66. Global Pneumococcal Vaccine Revenue Market Share by End User (2021–2026)

Table 67. Global Pneumococcal Vaccine Revenue Market Share by End User (2027–2032)

Table 68. Global Pneumococcal Vaccine Price (USD/Dose) by End User (2021–2026)

Table 69. Global Pneumococcal Vaccine Price (USD/Dose) by End User (2027–2032)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 73. Pfizer Pneumococcal Vaccine Product

Table 74. Pfizer Recent Developments/Updates

Table 75. GSK Company Information

Table 76. GSK Description and Business Overview

Table 77. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 78. GSK Pneumococcal Vaccine Product

Table 79. GSK Recent Developments/Updates

Table 80. MSD Company Information

Table 81. MSD Description and Business Overview

Table 82. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 83. MSD Pneumococcal Vaccine Product

Table 84. MSD Recent Developments/Updates

Table 85. Sanofipasteur Company Information

Table 86. Sanofipasteur Description and Business Overview

Table 87. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 88. Sanofipasteur Pneumococcal Vaccine Product

Table 89. Sanofipasteur Recent Developments/Updates

Table 90. CDIBP Company Information

Table 91. CDIBP Description and Business Overview

Table 92. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 93. CDIBP Pneumococcal Vaccine Product

Table 94. CDIBP Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Pneumococcal Vaccine Distributors List

Table 98. Pneumococcal Vaccine Customers List

Table 99. Pneumococcal Vaccine Market Trends

Table 100. Pneumococcal Vaccine Market Drivers

Table 101. Pneumococcal Vaccine Market Challenges

Table 102. Pneumococcal Vaccine Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pneumococcal Vaccine

Figure 2. Global Pneumococcal Vaccine Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Pneumococcal Vaccine Market Share by Type: 2025 & 2032

Figure 4. PPSV 23 Product Picture

Figure 5. PCV 7/13 Product Picture

Figure 6. PCV 10 Product Picture

Figure 7. Global Pneumococcal Vaccine Market Value by End User (US$ Million), 2021–2032

Figure 8. Global Pneumococcal Vaccine Market Share by End User: 2025 & 2032

Figure 9. Child

Figure 10. Adult

Figure 11. Global Pneumococcal Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Pneumococcal Vaccine Market Size (US$ Million), 2021–2032

Figure 13. Global Pneumococcal Vaccine Sales (K Doses), 2021–2032

Figure 14. Global Pneumococcal Vaccine Average Price (USD/Dose), 2021–2032

Figure 15. Pneumococcal Vaccine Report Years Considered

Figure 16. Pneumococcal Vaccine Sales Share by Manufacturers in 2025

Figure 17. Global Pneumococcal Vaccine Revenue Share by Manufacturers in 2025

Figure 18. Top 5 and Top 10 Global Pneumococcal Vaccine Players: Market Share by Revenue in Pneumococcal Vaccine in 2025

Figure 19. Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 20. Global Pneumococcal Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 21. North America Pneumococcal Vaccine Sales Market Share by Country (2021–2032)

Figure 22. North America Pneumococcal Vaccine Revenue Market Share by Country (2021–2032)

Figure 23. U.S. Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Canada Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Europe Pneumococcal Vaccine Sales Market Share by Country (2021–2032)

Figure 26. Europe Pneumococcal Vaccine Revenue Market Share by Country (2021–2032)

Figure 27. Germany Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. France Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. U.K. Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Italy Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Russia Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Asia Pacific Pneumococcal Vaccine Sales Market Share by Region (2021–2032)

Figure 33. Asia Pacific Pneumococcal Vaccine Revenue Market Share by Region (2021–2032)

Figure 34. China Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Japan Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. South Korea Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. India Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Australia Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. China Taiwan Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Indonesia Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Thailand Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Malaysia Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Philippines Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Latin America Pneumococcal Vaccine Sales Market Share by Country (2021–2032)

Figure 45. Latin America Pneumococcal Vaccine Revenue Market Share by Country (2021–2032)

Figure 46. Mexico Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Brazil Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Argentina Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Middle East and Africa Pneumococcal Vaccine Sales Market Share by Country (2021–2032)

Figure 50. Middle East and Africa Pneumococcal Vaccine Revenue Market Share by Country (2021–2032)

Figure 51. Turkey Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Saudi Arabia Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. U.A.E Pneumococcal Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Global Sales Market Share of Pneumococcal Vaccine by Type (2021–2032)

Figure 55. Global Revenue Market Share of Pneumococcal Vaccine by Type (2021–2032)

Figure 56. Global Pneumococcal Vaccine Price (USD/Dose) by Type (2021–2032)

Figure 57. Global Sales Market Share of Pneumococcal Vaccine by End User (2021–2032)

Figure 58. Global Revenue Market Share of Pneumococcal Vaccine by End User (2021–2032)

Figure 59. Global Pneumococcal Vaccine Price (USD/Dose) by End User (2021–2032)

Figure 60. Pneumococcal Vaccine Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Polyvalent Streptococcus Pneumococcal Vaccines Market Research Report 2025

Global Pneumonia Vaccine Market Insights Forecast to 2030

Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Pneumococcal Vaccine Polyvalent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bacterial Vaccines for Humans Market Research Report 2024

Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Research Report 2024

Global 23 Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pneumococcal Testing Market Research Report 2024

Global Meningococcal Infections Vaccine Market Insights Forecast to 2030

Global Pneumonia Therapeutics Market Research Report 2024

Global Vaccines For Children Market Insights Forecast to 2030

Global Mycoplasma Hyopneumoniae Vaccine Market Research Report 2024

Global Poliomyelitis Vaccine Market Research Report 2025

Meningococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibacterial Vaccines Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions